AKYA חוב לטווח קצר להון Akoya Biosciences, Inc.

Akoya Biosciences develops cutting-edge solutions for studying cellular structures, targeting pharmaceutical companies and oncologists. This daily price chart on GURU.Markets reflects the company's assets, where the current metric stands at 0.00. Patents for the PhenoCycler system create a robust barrier to entry for competitors, ensuring a steady stream of revenue from consumables. Despite a dependence on research spending, the demand for personalized medicine guarantees long-term growth.

For an investor in Akoya Biosciences (AKYA), this indicator serves as a liquidity metric by comparing liabilities with a maturity of up to one year against total capital; analyzing the change in the share of short-term liabilities within the capital allows for an assessment of how stable the financing for the purchase of expensive equipment remains amid limited university capex budgets, provided there is a steady cash flow from the sale of premium reagents.